Oncology & Cancer

No benefit of induction chemo, high-dose boost in anal cancer

(HealthDay) -- Neither induction chemotherapy (ICT) nor high-dose radiation boost is associated with an improvement in five-year colostomy-free survival (CFS) in patients with locally advanced anal canal carcinoma (LAACC), ...

Oncology & Cancer

Use of local RVUs could aid CT unit management

(HealthDay)—There is considerable variation in computed tomography (CT) radiologists' reporting workload across different tests, with a corresponding need for methods that normalize radiologist work to address reporting ...

Oncology & Cancer

ASTRO: Shorter radiation OK for early breast cancers

(HealthDay)—Hypofractionated radiation therapy with incorporated boost over a shorter period of time treats early-stage breast cancer as well as longer, conventional radiation therapy, a new study suggests. The findings ...

Oncology & Cancer

Diffusion-weighted imaging + MRI OK for undescended testes

(HealthDay)—Combined diffusion-weighted imaging (DWI) and magnetic resonance imaging (MRI) show a greater performance compared to conventional MRI alone for identification of non-palpable undescended testes (UDTs), according ...

Oncology & Cancer

Cancer patients in their 60s are tech-savvy

When cancer patients are given the choice, they are significantly more likely to use Web-based technology to answer questions about their quality of life six months after treatment, compared to a paper survey, according to ...

page 29 from 40